American Oriental Bioengineering

AOBI · OTC

$0.013+$0.0022 (+20.37%)TodayMarket closed ·
No price history for this range.

About AOBI

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of pharmaceutical and healthcare products. The firm is engaged in development, manufacture and commercialization of a broad range of pharmaceutical and healthcare products. The Company’s business consists of prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products. Two flagship prescription pharmaceutical products marketed in China are Shuanghuanglian Lyophilized Injection Powder, or SHL Injection Powder, and Cease Enuresis Soft Gel, or CE Gel. Over-the-counter pharmaceutical products are similar to its prescription pharmaceutical products in that they need approval from the SFDA. Nutraceutical products are intended for the overall well-being. The firm also sells several nutraceutical products, including its soybean peptide-based drinks, tablets, powder and instant coffee.

Employees
4,295
Headquarters
Shenzhen, Guangdong
Listed
Dec 18, 2006
Sector
Consumer Staples
Industry
Personal Care Products

Leadership

American Oriental Bioengineering executives
NameTitleSince
Shujun Liu—2001
Yanchun Li—2002
Xiaopeng Xu——
Yan Gao——
Jun Min—2002
Cosimo Patti——
Xianmin Wang——
Baiqing Zhang——

Similar companies

Companies in the same industry as American Oriental Bioengineering

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.